MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Myriad Genetics Total Current Liabilities 2011-2026 | MYGN
Annual Total Current Liabilities Myriad Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 164 M | 156 M | 137 M | 204 M | 146 M | 118 M | 102 M | 218 M | 72.3 M | 68.7 M | 80.6 M | 64.5 M | 45 M | 34.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 218 M | 34.4 M | 115 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 23.0 | 2.86 % | $ 248 M |  China |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.6 | -0.22 % | $ 2.03 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
5.75 M | $ 6.1 | 1.16 % | $ 179 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 39.93 | -1.67 % | $ 1.11 B | USA |
 |
Danaher Corporation
DHR
|
6.8 B | $ 234.99 | -0.25 % | $ 172 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 12.98 | 6.97 % | $ 368 M | Israel |
 |
DexCom
DXCM
|
1.56 B | $ 68.47 | -2.33 % | $ 26.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
78.1 M | $ 17.5 | -7.41 % | $ 941 M | USA |
 |
Celcuity
CELC
|
31.7 M | $ 105.54 | -3.33 % | $ 4.16 B | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
2.5 M | $ 3.4 | 3.66 % | $ 108 K | USA |
 |
Exact Sciences Corporation
EXAS
|
732 M | $ 101.77 | 0.14 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 27.9 | -0.39 % | $ 844 M | USA |
 |
Guardant Health
GH
|
226 M | $ 107.75 | -1.98 % | $ 13.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
544 M | $ 48.19 | 1.71 % | $ 10.7 B |  Niderland |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 146.41 | -2.48 % | $ 23.3 B | USA |
 |
Charles River Laboratories International
CRL
|
994 M | $ 214.0 | -1.51 % | $ 11 B | USA |
 |
IQVIA Holdings
IQV
|
6.96 B | $ 243.4 | -0.36 % | $ 44.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.17 B | $ 177.06 | -0.64 % | $ 19.7 B | USA |
|
Biodesix
BDSX
|
14.3 M | $ 5.77 | -3.27 % | $ 748 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
3.33 B | $ 254.76 | 0.43 % | $ 21.4 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 189.39 | -6.67 % | $ 15.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.07 B | $ 708.9 | -0.79 % | $ 58.5 B | USA |
 |
Lantheus Holdings
LNTH
|
241 M | $ 68.27 | -1.59 % | $ 4.72 B | USA |
 |
Agilent Technologies
A
|
1.71 B | $ 145.56 | -1.51 % | $ 44.3 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.83 | 1.8 % | $ 6.5 M | USA |
 |
Bioventus
BVS
|
175 M | $ 8.0 | 5.12 % | $ 501 M | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
3.14 M | $ 23.85 | 2.49 % | $ 31 M | USA |
 |
Mettler-Toledo International
MTD
|
1.17 B | $ 1 461.94 | -0.56 % | $ 31 B |  Schweiz |
 |
ENDRA Life Sciences
NDRA
|
605 K | $ 4.64 | 1.75 % | $ 2.49 M | USA |